An outbreak of mumps in a population partially vaccinated with the Rubini strain

被引:52
作者
Germann, D
Strohle, A
Eggenberger, K
Steiner, CA
Matter, L
机构
[1] Institute of Medical Microbiology, University of Bern, Bern
[2] Paediatric Practice, Yverdon-les-bains
[3] Paediatric Practice, Moutier
[4] Institute of Medical Microbiology, University of Bern, CH-3010 Bern
关键词
D O I
10.3109/00365549609027163
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Since 1991, 6 years after the recommendation of universal childhood triple vaccination against measles, mumps and rubella (M + M + R), Switzerland has been confronted with an increasing number of mumps cases affecting both vaccinated and unvaccinated children. The M + M + R vaccine mainly used in the Swiss population after 1986 contains the highly attenuated Rubini strain of mumps virus. We analysed an outbreak of 102 suspected mumps cases by virus isolation, determination of IgM antibodies to mumps virus in 27 acute phase sera, and verification of vaccination histories. Mumps was confirmed by virus isolation in 88 patients, of whom 72 had previously received the Rubini vaccine strain. IgM antibodies to mumps virus were detected in 24/27 acute phase serum samples. A group of 92 subjects from the same geographic area without signs of mumps virus infection served as controls. Ige antibodies to mumps virus and vaccination status were assessed in these children. The vaccination rate in these controls was 61%, with equal seropositivity for unvaccinated and Rubini-vaccinated subjects. These data support other recent reports which indicate an insufficient protective efficacy of current mumps vaccines.
引用
收藏
页码:235 / 238
页数:4
相关论文
共 37 条
  • [1] DIRECTLY TRANSMITTED INFECTIOUS-DISEASES - CONTROL BY VACCINATION
    ANDERSON, RM
    MAY, RM
    [J]. SCIENCE, 1982, 215 (4536) : 1053 - 1060
  • [2] THE EPIDEMIOLOGY OF MUMPS IN THE UK - A PRELIMINARY-STUDY OF VIRUS TRANSMISSION, HERD-IMMUNITY AND THE POTENTIAL IMPACT OF IMMUNIZATION
    ANDERSON, RM
    CROMBIE, JA
    GRENFELL, BT
    [J]. EPIDEMIOLOGY AND INFECTION, 1987, 99 (01) : 65 - 84
  • [3] BIEDEL CW, 1988, AM J DIS CHILD, V132, P678
  • [4] LABORATORY MARKERS FOR OVER-ATTENUATION OF MUMPS VACCINE VIRUS
    BORISKIN, YS
    KAPTSOVA, TI
    LOTTE, VD
    SKVORTSOVA, OI
    ORVELL, C
    [J]. VACCINE, 1988, 6 (06) : 483 - 488
  • [5] SUSTAINED TRANSMISSION OF MUMPS IN A HIGHLY VACCINATED POPULATION - ASSESSMENT OF PRIMARY VACCINE FAILURE AND WANING VACCINE-INDUCED IMMUNITY
    BRISS, PA
    FEHRS, LJ
    PARKER, RA
    WRIGHT, PF
    SANNELLA, EC
    HUTCHESON, RH
    SCHAFFNER, W
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (01) : 77 - 82
  • [6] BUHNAK EB, 1966, P SOC EXP BIOL MED, V13, P769
  • [7] THE IMMUNIZING EFFECT AND REACTOGENICITY OF 2 LIVE ATTENUATED MUMPS-VIRUS VACCINES IN SWEDISH SCHOOLCHILDREN
    CHRISTENSON, B
    HELLER, L
    BOTTIGER, M
    [J]. JOURNAL OF BIOLOGICAL STANDARDIZATION, 1983, 11 (04): : 323 - 331
  • [8] PERSPECTIVES ON THE RELATIVE RESURGENCE OF MUMPS IN THE UNITED-STATES
    COCHI, SL
    PREBLUD, SR
    ORENSTEIN, WA
    [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1988, 142 (05): : 499 - 507
  • [9] GERMANN D, 1993, 9 INT C VIR GLASG
  • [10] IMMUNE-RESPONSE TO SIMULTANEOUS ADMINISTRATION OF A COMBINED MEASLES, MUMPS AND RUBELLA VACCINE WITH BOOSTER DOSES OF DIPHTHERIA-TETANUS AND POLIOVIRUS VACCINE
    GIAMMANCO, G
    LIVOLTI, S
    SALEMI, I
    BILANCIA, GG
    MAURO, L
    [J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1993, 9 (02) : 199 - 202